These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 19685493)
1. Toll-like receptors on B-CLL cells: expression and functional consequences of their stimulation. Rozková D; Novotná L; Pytlík R; Hochová I; Kozák T; Bartůnková J; Spísek R Int J Cancer; 2010 Mar; 126(5):1132-43. PubMed ID: 19685493 [TBL] [Abstract][Full Text] [Related]
2. Expression and function of toll like receptors in chronic lymphocytic leukaemia cells. Muzio M; Scielzo C; Bertilaccio MT; Frenquelli M; Ghia P; Caligaris-Cappio F Br J Haematol; 2009 Feb; 144(4):507-16. PubMed ID: 19036098 [TBL] [Abstract][Full Text] [Related]
3. The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia. Rybka J; Butrym A; Wróbel T; Jaźwiec B; Bogucka-Fedorczuk A; Poręba R; Kuliczkowski K Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):147-150. PubMed ID: 28083607 [TBL] [Abstract][Full Text] [Related]
4. TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia. Szymańska A; Bojarska-Junak A; Drobiecki A; Tomczak W; Roliński J; Hus M; Hus I Arch Immunol Ther Exp (Warsz); 2019 Feb; 67(1):55-65. PubMed ID: 30196472 [TBL] [Abstract][Full Text] [Related]
5. Stimulation of iNOS expression and apoptosis resistance in B-cell chronic lymphocytic leukemia (B-CLL) cells through engagement of Toll-like receptor 7 (TLR-7) and NF-kappaB activation. Hammadi A; Billard C; Faussat AM; Kolb JP Nitric Oxide; 2008 Sep; 19(2):138-45. PubMed ID: 18474259 [TBL] [Abstract][Full Text] [Related]
6. A distinct Toll-like receptor repertoire in human tonsillar B cells, directly activated by PamCSK, R-837 and CpG-2006 stimulation. Månsson A; Adner M; Höckerfelt U; Cardell LO Immunology; 2006 Aug; 118(4):539-48. PubMed ID: 16780564 [TBL] [Abstract][Full Text] [Related]
7. CD38 expression levels in chronic lymphocytic leukemia B cells are associated with activation marker expression and differential responses to interferon stimulation. Pittner BT; Shanafelt TD; Kay NE; Jelinek DF Leukemia; 2005 Dec; 19(12):2264-72. PubMed ID: 16208411 [TBL] [Abstract][Full Text] [Related]
8. TLR2 may influence the behavior of the malignant clone in B-CLL. Antosz H; Sajewicz J; Marzec-Kotarska B; Dmoszyńska A; Baszak J; Jargiełło-Baszak M Blood Cells Mol Dis; 2012 Jun; 49(1):32-40. PubMed ID: 22521894 [TBL] [Abstract][Full Text] [Related]
9. Total expression of HLA-G and TLR-9 in chronic lymphocytic leukemia patients. Własiuk P; Tomczak W; Zając M; Dmoszyńska A; Giannopoulos K Hum Immunol; 2013 Dec; 74(12):1592-7. PubMed ID: 23994589 [TBL] [Abstract][Full Text] [Related]
10. In vitro sensitivity of CLL cells to fludarabine may be modulated by the stimulation of Toll-like receptors. Fonte E; Apollonio B; Scarfò L; Ranghetti P; Fazi C; Ghia P; Caligaris-Cappio F; Muzio M Clin Cancer Res; 2013 Jan; 19(2):367-79. PubMed ID: 23224401 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of type 4 cyclic nucleotide phosphodiesterase blocks intracellular TLR signaling in chronic lymphocytic leukemia and normal hematopoietic cells. Tan Y; Watkins AA; Freeman BB; Meyers JA; Rifkin IR; Lerner A J Immunol; 2015 Jan; 194(1):101-12. PubMed ID: 25416804 [TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor agonists in the treatment of chronic lymphocytic leukemia. Spaner DE; Masellis A Leukemia; 2007 Jan; 21(1):53-60. PubMed ID: 17066089 [TBL] [Abstract][Full Text] [Related]
14. Different expression of CD180, CD284 and CD14 receptors on the CD19+ subpopulation of normal and B-CLL lymphocytes. Antosz H; Sajewicz J; Marzec-Kotarska B; Kocki J; Dmoszyńska A Folia Histochem Cytobiol; 2009; 47(4):593-8. PubMed ID: 20430725 [TBL] [Abstract][Full Text] [Related]
15. Effects of Toll-like receptor 7 and Toll-like receptor 9 signaling stimulators and inhibitors on chronic lymphocytic leukemia cells ex vivo and their interactions with cladribine. Wolska A; Cebula-Obrzut B; Smolewski P; Robak T Leuk Lymphoma; 2013 Jun; 54(6):1268-78. PubMed ID: 23078646 [TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia. Ibrahim S; Jilani I; O'Brien S; Rogers A; Manshouri T; Giles F; Faderl S; Thomas D; Kantarjian H; Keating M; Albitar M Cancer; 2003 Apr; 97(8):1914-9. PubMed ID: 12673718 [TBL] [Abstract][Full Text] [Related]
19. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression. Hojjat Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Shamsian Khoramabadi A; Rabbani H; Shokri F Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522 [TBL] [Abstract][Full Text] [Related]
20. Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia. Cavallini C; Lovato O; Bertolaso A; Zoratti E; Malpeli G; Mimiola E; Tinelli M; Aprili F; Tecchio C; Perbellini O; Scarpa A; Zamò A; Cassatella MA; Pizzolo G; Scupoli MT Oncotarget; 2015 Oct; 6(31):32061-74. PubMed ID: 26393680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]